TNPSC Thervupettagam

ZyCoV-D vaccine

August 24 , 2021 1117 days 785 0
  • The Drug Controller General of India has approved ZyCoV-D vaccine by Zydus Cadila for Emergency Use Authorization.
  • ZyCoV-D vaccine is the world’s first and India’s indigenously developed DNA-based vaccine for COVID-19.
  • It will be administered to humans including children and adults aged 12 years and more.
  • Zydus Cadila developed this vaccine in partnership with the Department of Biotechnology under Mission COVID Suraksha.
  • It will be implemented by Biotechnology Industry Research Assistance Council (BIRAC).
  • It is a three-dose vaccine.
  • Zydus Cadila is also known as Cadila Healthcare Limited.
  • It is headquartered in Ahmedabad, Gujarat.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories